← Leaderboards
Glen E Cooke
Ohio State University
$670,339
Attributed
$670,339
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $139.2K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$670,339 · 1
By mechanism
K23$670,339 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Chyke Abadama Doubeni$16,866,019
- Rebecca D Jackson$123,151,116
- Vera Novak$7,423,251
- Helen M Chamberlin$1,430,883
- John C Kissel$1,216,123
Others in their field
Top investigators on “Platelet Activation”
- Keri Hammel · The Emmes Company, Llc$41,748,603
- Mortimer Poncz · University Of Pennsylvania$33,180,460
- Susan Fera Assmann · New England Research Institutes, Inc.$32,902,030
- Satya P. Kunapuli · Temple University$28,131,560
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$27,474,076
- Bruce Furie · Beth Israel Deaconess Medical Center$23,186,909
Research focus
Platelet ActivationDrug Screening /EvaluationAspirinClopidogrelClinical TrialsMyocardial InfarctionPharmacogeneticsStatistics /BiometryCardiovascular Disorder DiagnosisInterviewHuman SubjectClinical ResearchAngiographyIntegrinsHuman Therapy EvaluationLongitudinal Human StudyEnzyme ActivityCardiovascular Disorder ChemotherapyElectrocardiographyGenetic PolymorphismAnticoagulantsArtery OcclusionCoronary DisorderBlood Chemistry
Grant awards (5)
Pharmacogenetic Antiplatelet Strategies in CHD Patients$139,226
K23 · FY2007 · HL · contact PI
Pharmacogenetic Antiplatelet Strategies in CHD Patients$136,571
K23 · FY2006 · HL · contact PI
Pharmacogenetic Antiplatelet Strategies in CHD Patients$133,992
K23 · FY2005 · HL
Pharmacogenetic Antiplatelet Strategies in CHD Patients$131,490
K23 · FY2004 · HL
Pharmacogenetic Antiplatelet Strategies in CHD Patients$129,060
K23 · FY2003 · HL